Estimating systemic exposure to levonorgestrel from an oral contraceptive
Estimating systemic exposure to levonorgestrel from an oral contraceptive
复制标题
DOI:
10.1016/j.contraception.2016.12.007
复制
发表时间:
2017-04-01
期刊:
影响因子:
2.9
通讯作者:
Cremers, Serge
中科院分区:
文献类型:
--
作者:
Basaraba, Cale N.;Westhoff, Carolyn L.;Cremers, Serge
Objective: The gold standard for measuring oral contraceptive (OC) pharmacokinetics is the 24-h steady-state area under the curve (AUC). We conducted this study to assess whether limited sampling at steady state or measurements following use of one or two OCs could provide an adequate proxy in epidemiological studies for the progestin 24-h steady-state AUC of a particular OC.Study design: We conducted a 13-sample, 24-h pharmacokinetic study on both day 1 and day 21 of the first cycle of a monophasic OC containing 30-mcg ethinyl estradiol and 150-mcg levonorgestrel (LNG) in 17 normal-weight healthy White women and a single-dose 9 sample study of the same OC after a 1-month washout. We compared the 13-sample steady-state results with several steady-state and single dose results calculated using parsimonious sampling schemes.Results: The 13-sample steady-state 24-h LNG AUC was highly correlated with the steady-state 24-h trough value [r=0.95; 95% confidence interval (0.85, 0.98)] and with the steady-state 6-, 8-, 12- and 16-h values (0.92 5 r-0.95). The trough values after one or two doses were moderately correlated with the steady-state 24-h AUC value [r=0.70; 95% CI (0.27, 0.90) and 0.77; 95% CI (0.40, 0.92), respectively].Conclusions: Single time-point concentrations at steady state and after administration of one or two OCs gave highly to moderately correlated estimates of steady-state LNG AUC. Using such measures could facilitate prospective pharmaco-epidemiologic studies of the OC and its side effects. (C) 2017 Elsevier Inc. All rights reserved.